This HTML5 document contains 128 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n12http://dx.doi.org/10.1155/2017/
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37624975
rdf:type
wikibase:Item
schema:description
wissenschaftlicher Artikel videnskabelig artikel scientific article published on 22 January 2017 vědecký článek article scientifique مقالة علمية نشرت في 22 يناير 2017 artículu científicu espublizáu en 2017 научни чланак artigo científico наукова стаття, опублікована в січні 2017 wetenschappelijk artikel article científic articolo scientifico vedecký článok bilimsel makale vetenskaplig artikel
p:P577
wds:Q37624975-586A391C-FEC3-47ED-965A-B5934E04E7B7
wdt:P577
2017-01-22T00:00:00Z
p:P407
wds:Q37624975-ECB9F1BC-EA63-4268-9D53-7083BF756E28
wdt:P407
wd:Q1860
p:P2860
wds:Q37624975-A72EDB2C-15CC-4C4B-BE9F-BD8A998A1F01 wds:Q37624975-D96D94B4-40D9-46DA-916C-13B2F76EF039 wds:Q37624975-DAF5FB37-AE37-4C56-930E-B6277080C1F2 wds:Q37624975-C7AD92E2-5B70-4BFD-9724-0E40BD45534D wds:Q37624975-CB89F2D3-6189-47EB-9654-4373479C274B wds:Q37624975-D3FFA7A4-F6DF-4CF9-945F-8478B41F62A8 wds:Q37624975-D4733F55-F44C-4850-8ACD-3F84891CC9E7 wds:Q37624975-EAB96568-CBBD-4C89-963F-0C2E1ED2956A wds:Q37624975-DD095D1A-2E26-4706-90AA-4EE4578DCAB3 wds:Q37624975-E77474E3-F595-4CE3-A4A9-A2D1DADE7726 wds:Q37624975-F4EFFAA5-F2A4-4A74-93B9-517CF302A142 wds:Q37624975-FA18AA12-67E1-4C58-A50F-B49616491985 wds:Q37624975-0E2F62EF-40F5-4B2C-9FEE-E0A041D1E766 wds:Q37624975-12F22277-6B8A-4153-BD2D-6F7A339FFBE4 wds:Q37624975-13FBB48B-46DF-4919-8A3E-FA229529DED1 wds:Q37624975-1FF00739-A8BA-45BF-A5E8-672B5B34C4D7 wds:Q37624975-018E6AF5-D397-462D-88A5-EF875FDB6414 wds:Q37624975-07BEA4ED-DC9A-475E-AF57-FFF1CEB1C9E1 wds:Q37624975-3B6E535B-84FD-4313-A2A6-A9AB0BD601A1 wds:Q37624975-3C9760AB-E9AF-4AE1-8B81-47413581F9B4 wds:Q37624975-4008369A-1581-4687-B13F-FDEE8992C301 wds:Q37624975-460C240E-9FD6-4335-A618-DC8652C5C16E wds:Q37624975-85B46926-337F-4C08-9714-ED0CACF24E3E wds:Q37624975-870CA9C3-79F5-4E7F-B16A-FFC2FAE06EFC wds:Q37624975-966CF59B-69EF-4723-8648-003395BB5537 wds:Q37624975-60A0BE4E-AE09-4601-A35D-C4475BA3B55C wds:Q37624975-704D37E3-83D3-4F52-AE78-1F8CD70A9EDB wds:Q37624975-7A6AA92B-DE8C-4697-8439-0E919BC60C1F wds:Q37624975-ACAD4F41-CD9C-473B-A9DD-B2B258F64276 wds:Q37624975-BD26C6FE-78E9-48CC-A71D-58F8226E823C wds:Q37624975-BDA9CD49-7925-4E86-A71A-BD9DE7ED0BD3 wds:Q37624975-9C5724CA-984B-404E-B3D6-25F5703FCBC1 wds:Q37624975-A405D838-8F8E-41D2-A8A3-6C2461853DC2 wds:Q37624975-A5203467-E873-4151-9279-2D893678A026
wdt:P2860
wd:Q46289569 wd:Q37403446 wd:Q44017962 wd:Q51162872 wd:Q36608175 wd:Q34009569 wd:Q26750267 wd:Q51375156 wd:Q38294476 wd:Q35919111 wd:Q53157154 wd:Q87439306 wd:Q59430118 wd:Q52180321 wd:Q73564256 wd:Q41606565 wd:Q70165450 wd:Q39085678 wd:Q38344674 wd:Q33697467 wd:Q28235042 wd:Q53018375 wd:Q37272978 wd:Q37761015 wd:Q36371512 wd:Q40324762 wd:Q46594762 wd:Q37338003 wd:Q53497965 wd:Q37926914 wd:Q37029424 wd:Q59430741 wd:Q34461344 wd:Q40573161
p:P2093
wds:Q37624975-AC5BBAA7-295D-4D19-BA03-3D87A77D08A2
wdt:P2093
Feride Shkembi
rdfs:label
In Vitro and In Vivo Evaluation of Commercially Available Fibrin Gel as a Carrier of Alendronate for Bone Tissue Engineering In Vitro and In Vivo Evaluation of Commercially Available Fibrin Gel as a Carrier of Alendronate for Bone Tissue Engineering In Vitro and In Vivo Evaluation of Commercially Available Fibrin Gel as a Carrier of Alendronate for Bone Tissue Engineering
skos:prefLabel
In Vitro and In Vivo Evaluation of Commercially Available Fibrin Gel as a Carrier of Alendronate for Bone Tissue Engineering In Vitro and In Vivo Evaluation of Commercially Available Fibrin Gel as a Carrier of Alendronate for Bone Tissue Engineering In Vitro and In Vivo Evaluation of Commercially Available Fibrin Gel as a Carrier of Alendronate for Bone Tissue Engineering
schema:name
In Vitro and In Vivo Evaluation of Commercially Available Fibrin Gel as a Carrier of Alendronate for Bone Tissue Engineering In Vitro and In Vivo Evaluation of Commercially Available Fibrin Gel as a Carrier of Alendronate for Bone Tissue Engineering In Vitro and In Vivo Evaluation of Commercially Available Fibrin Gel as a Carrier of Alendronate for Bone Tissue Engineering
p:P50
wds:Q37624975-FB9B4316-689C-4BF4-98F8-6CE1D35232CB wds:Q37624975-4FAF8DFF-2062-447C-BFAB-69AA39CE0C68
wdt:P50
wd:Q86814778 wd:Q96066271
p:P1476
wds:Q37624975-DC2FCDC3-D301-4B15-B2ED-8061BC2FE240
wdt:P1476
In Vitro and In Vivo Evaluation of Commercially Available Fibrin Gel as a Carrier of Alendronate for Bone Tissue Engineering
p:P304
wds:Q37624975-49E62F4A-1DAC-4C77-BD58-2B47B7F8FDD9
wdt:P304
6434169
p:P31
wds:Q37624975-4AFE4408-4CFF-4187-82F3-AC4DC034C20A
wdt:P31
wd:Q13442814
p:P921
wds:Q37624975-F0E9CDB7-F91F-4A05-9429-ED738EFF43D7
wdt:P921
wd:Q1540285
p:P698
wds:Q37624975-E19A11A3-4D31-4AB1-BE8E-1393258612F3
wdtn:P698
n7:28210623
wdt:P698
28210623
p:P1433
wds:Q37624975-8D973747-8BC1-4106-8743-C73EB9B1E77B
wdt:P1433
wd:Q17509958
p:P478
wds:Q37624975-0102C01C-0C0A-4BB9-A2A8-BCFFAC7739F9
wdt:P478
2017
p:P356
wds:Q37624975-77090065-09A0-415D-A942-D5946151589F
wdtn:P356
n12:6434169
wdt:P356
10.1155/2017/6434169
p:P275
wds:Q37624975-D95EF650-D272-4D11-B1FE-4B44991E83F3
p:P6216
wds:Q37624975-EBC06EF3-CD5A-4632-BED1-343917ABE09E
wdt:P275
wd:Q20007257
wdt:P6216
wd:Q50423863
p:P932
wds:Q37624975-D8087D3E-9C4F-4833-B32B-2A8278FFAF8A
wdt:P932
5292194